#BioGRID Chemical Interaction ID	BioGRID Gene ID	Entrez Gene ID	Systematic Name	Official Symbol	Synonyms	Organism ID	Organism	Action	Interaction Type	Author	Pubmed ID	BioGRID Publication ID	BioGRID Chemical ID	Chemical Name	Chemical Synonyms	Chemical Brands	Chemical Source	Chemical Source ID	Molecular Formula	Chemical Type	ATC Codes	CAS Number	Curated By	Method	Method Description	Related BioGRID Gene ID	Related Entrez Gene ID	Related Systematic Name	Related Official Symbol	Related Synonyms	Related Organism ID	Related Organism	Related Type	Notes	InChIKey
127	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
128	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	LaMontagne KR (2006)	16505108	171793	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
129	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Kokhaei P (2007)	17575216	171792	12	Darbepoetin alfa	Darbepoetin|Darbepoetin alfa,recombinant	aranesp -(hsa-free)|aranesp|ar	DRUGBANK	DB00012	C815H1317N233O241S5	biologic	B03XA02	209810-58-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
189	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
190	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	LaMontagne KR (2006)	16505108	171793	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
191	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Kokhaei P (2007)	17575216	171792	16	Erythropoietin	Epoetin alfa|Epoetin omega|SH-polypeptide-72|Epoetin gamma rDNA|Epoetin beta rDNA|ESF|Epoetin kappa|Erythropoietin (human, recombinant)|Epoetin alfa rDNA|Epoetin alfa, recombinant|E.P.O.|Epoetin gamma|Erythropoiesis stimulating factor|Epoetin epsilon|Epoetin beta|Erythropoietin (recombinant human)	eprex sterile solution 5000iu/	DRUGBANK	DB00016	C815H1317N233O241S5	biologic	B03XA01	11096-26-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
2485	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2486	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Henley JM (1993)	7679210	173247	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2487	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2488	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Stein E (1992)	1279377	173276	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2489	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Li F (1995)	7838123	173277	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2512	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Miglio G (2007)	17662248	173213	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
2513	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Verkhratsky A (2007)	17229973	173286	136	L-Glutamic Acid	(S)-Glutamic acid|(2S)-2-Aminopentanedioic acid|L-Glutamate|Glutamic acid|(S)-2-Aminopentanedioic acid|L-Glutaminic acid|Glu	primene 10%|aminosyn ii 5% inj	DRUGBANK	DB00142	C5H9NO4	small molecule	-	56-86-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WHUUTDBJXJRKMK-VKHMYHEASA-N
4019	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	179	Lorazepam	Lormetazepam|Ativan|O-Chlorooxazepam|Methyllorazepam|()-Lorazepam|N-Methyllorazepam|O-Chloroxazepam	pms-lorazepam tab 0.5mg|apo-lo	DRUGBANK	DB00186	C15H10Cl2N2O2	small molecule	N05BA06|N05CD06|N05BA56	846-49-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DIWRORZWFLOCLC-UHFFFAOYSA-N
4061	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Smeyatsky N (1992)	1585214	174217	182	Ethchlorvynol	3-(beta-chlorovinyl)-1-pentyn-3-ol|Placidyl|1-chloro-3-ethyl-1-penten-4-yn-3-ol|ethyl -chlorovinyl ethynyl carbinol|1-Chloro-3-ethyl-pent-1-en-4-yn-3-ol|3-(-chlorovinyl)-1-pentyn-3-ol|-chlorovinyl ethyl ethynyl carbinol	placidyl cap 200mg|placidyl ca	DRUGBANK	DB00189	C7H9ClO	small molecule	N05CM08	113-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEHYJZXQEQOSON-AATRIKPKSA-N
4483	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Grasshoff C (2006)	16973644	174521	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4484	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Greenblatt EP (2001)	11465594	174520	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4485	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Franks NP (2006)	16402123	174522	221	Enflurane	Efrane|Enflurane|Alyrane|Ethrane|Enflurano|2-chloro-1,1,2-trifluoroethyl difluoromethyl ether|Enfluranum|Methylflurether	enflurane|ethrane liq inh|ethr	DRUGBANK	DB00228	C3H2ClF5O	small molecule	N01AB04	13838-16-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JPGQOUSTVILISH-UHFFFAOYSA-N
4515	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4516	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Giersch A (2010)	20138190	174534	224	Temazepam	Restoril	strazepam|nu-temazepam|phl-tem	DRUGBANK	DB00231	C16H13ClN2O2	small molecule	N05CD07	846-50-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEQDDYPDSLOBDC-UHFFFAOYSA-N
4607	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Mehta AK (1999)	10209232	174569	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4608	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4625	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4626	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	230	Butabarbital	Secbutabarbital|5-Sec-butyl-5-ethylbarbituric acid|5-Sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Butisol|5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methylpropyl)barbituric acid|Butabarbital	butisol sodium tab 30mg|butiso	DRUGBANK	DB00237	C10H16N2O3	small molecule	-	125-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRIHAIZYIMGOAB-UHFFFAOYSA-N
4633	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4634	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4638	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4639	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4640	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4641	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4642	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Cutrer FM (2001)	11279945	174583	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4643	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4644	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4645	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	234	Butalbital	allylbarbital|Butalbarbital|5-Allyl-5-(2-methylpropyl)barbituric acid|Itobarbital|Butalbitalum|allylbarbitone|5-isobutyl-5-allylbarbituric acid|Tetrallobarbital|5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione|5-Allyl-5-(2'-methyl-N-propyl) barbituric acid|5-Allyl-5-isobutylbarbituric acid|5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione|5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Allylbarbituric acid|Iso-butylallylbarbituric acid	allzital|ratio-tecnal c 1/4|ra	DRUGBANK	DB00241	C11H16N2O3	small molecule	-	77-26-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UZVHFVZFNXBMQJ-UHFFFAOYSA-N
4996	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4997	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Braga MF (2009)	19417176	174783	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4998	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
4999	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Nowakowska E (2009)	19998575	174787	266	Topiramate	Tipiramato|Topamax|Topiramatum|TPM|RWJ-17021|Tipiramate|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|Topiramate|McN-4853|Topiramato	dom-topiramate|act topiramate|	DRUGBANK	DB00273	C12H21NO8S	small molecule	N03AX11	97240-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJADKKWYZYXHBB-XBWDGYHZSA-N
5191	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	blocker	target	Ludolph AG (2010)	20423340	174993	282	Atomoxetine	Tomoxetine|Tomoxetinum|(-)-Tomoxetine|Tomoxetina	riva-atomoxetine|strattera|pms	DRUGBANK	DB00289	C17H21NO	small molecule	N06BA09	83015-26-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHGCDTVCOLNTBX-QGZVFWFLSA-N
5201	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5202	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Desai R (2009)	19741491	175004	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5203	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5204	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5205	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Martin LJ (2009)	19809285	175003	285	Etomidate	Etomidato|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|Etomidate|(+)-ethyl 1-(-methylbenzyl)imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|(+)-etomidate|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidatum|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester	amidate|etomidate	DRUGBANK	DB00292	C14H16N2O2	small molecule	N01AX07	33125-97-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPUKDXXFDDZOKR-LLVKDONJSA-N
5282	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5283	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5287	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5288	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5289	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5290	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5291	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5292	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5293	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	299	Talbutal	(RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione|sec-Butyl allyl barbituric acid|5-allyl-5-sec-butylbarbituric acid|Talbutale|Talbutalum|Lotusate	-	DRUGBANK	DB00306	C11H16N2O3	small molecule	N05CA07	115-44-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJVVMKUXKQHWJK-UHFFFAOYSA-N
5379	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5380	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5384	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Steinbach JH (2001)	11744750	175099	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5385	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5386	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5387	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5388	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Rahman M (2006)	16866778	175100	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5389	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Feigenspan A (2004)	15240758	175101	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5390	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Davies DL (2001)	11605100	175102	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5391	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5392	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5393	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5394	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5411	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	305	Pentobarbital	5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-(1-methyl-butyl)-pyrimidine-2,4,6-trione|Pentobarbital|5-ethyl-5-(sec-pentyl)barbituric acid|Pentobarbitone|Nembutal|5-ethyl-5-(1-methylbutyl)barbituric acid	nembutal sodium inj 50mg/ml|no	DRUGBANK	DB00312	C11H18N2O3	small molecule	N05CA01	76-74-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WEXRUCMBJFQVBZ-UHFFFAOYSA-N
5442	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	unknown	target	Farber NB (2002)	12192617	175117	306	Valproic Acid	2-Propylpentanoic Acid|4-heptanecarboxylic acid|di-n-propylacetic acid|2-Propylvaleric Acid|Di-n-propylessigsure|acide valproque|n-DPA|acidum valproicum|Valproate|Valproinsure|Dipropylacetic acid|2-propyl-pentanoic acid|2-n-propyl-n-valeric acid|DPA|VPA|cido valproico	dom-valproic acid syrup|divalp	DRUGBANK	DB00313	C8H16O2	small molecule	N03AG01	99-66-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NIJJYAXOARWZEE-UHFFFAOYSA-N
5521	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Punke MA (2007)	17456683	175184	314	Amitriptyline	3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene|Amitriptylinum|Amitriptilina|3-(10,11-dihydro-5H-Dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-dihydro-5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene|Amitriptyline|10,11-dihydro-N,N-Dimethyl-5H-dibenzo(a,D)heptalene-delta(5),gamma-propylamine|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene|Amitriptylin|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene	amitriptyline hydrochloride|ip	DRUGBANK	DB00321	C20H23N	small molecule	N06AA09|N06CA01	50-48-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRMDCWKBEZIMAB-UHFFFAOYSA-N
5728	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Bymaster FP (1996)	8822531	175320	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5867	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
5868	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	341	Clobazam	Clobazam|1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine|Clobazamum|7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione	onfi|clobazam-10|apo-clobazam 	DRUGBANK	DB00349	C16H13ClN2O2	small molecule	N05BA09	22316-47-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXOXHMZGEKVPMT-UHFFFAOYSA-N
6182	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Gonzalez LA (2009)	19244096	175633	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6183	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6184	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Rho JM (1997)	9067327	175634	363	Meprobamate	Meprobamat|Meprobamatum|Miltown|Equanil|Meprobamato|Meprobamic acid	282 mep tab|apo meprobamate ta	DRUGBANK	DB00371	C9H18N2O4	small molecule	N05CX01|N05BC01|N05BC51	57-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPPQSCRMBWNHMW-UHFFFAOYSA-N
6538	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6539	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	394	Eszopiclone	Eszopiclone|1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester|Estorra|(S)-Zopiclone|(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate|Esopiclone|(+)-Zopiclone|(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate|(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate	eszopiclone|lunesta	DRUGBANK	DB00402	C17H17ClN6O3	small molecule	N05CF04	138729-47-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-INIZCTEOSA-N
6576	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Verster JC (2004)	14978513	175867	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6577	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	396	Alprazolam	Alprazolam|8-Chloro-1-methyl-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine|Xanax	nu-alpraz tab 0.5mg|alprazolam	DRUGBANK	DB00404	C17H13ClN4	small molecule	N05BA12	28981-97-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VREFGVBLTWBCJP-UHFFFAOYSA-N
6672	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6673	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6677	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6678	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6679	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6680	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Peters JA (1988)	2850060	175928	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6681	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6682	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6683	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Miller LG (1988)	2906155	175929	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6684	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6685	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Kirkness EF (1986)	3006661	175927	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6686	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6703	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	410	Secobarbital	5-(1-Methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Secobarbitone|(+-)-Secobarbital|Secobarbitalum|5-allyl-5-(1-methylbutyl)barbituric acid|Seconal|5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Quinalbarbitone|5-Allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione|()-secobarbital	seconal sodium pulvule 240 0.1	DRUGBANK	DB00418	C12H18N2O3	small molecule	N05CA06	76-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQPKPCNLIDLUMF-UHFFFAOYSA-N
6831	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Pritchett DB (1990)	2157817	175975	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6832	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Smith AJ (2001)	11306694	175974	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6833	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6834	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Vlainic J (2009)	19345234	175976	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
6835	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	417	Zolpidem	Zolpidem|Zolpidemum|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide	zolpidem tartrate|zolpidem tar	DRUGBANK	DB00425	C19H21N3O	small molecule	N05CF02	82626-48-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZAFYATHCZYHLPB-UHFFFAOYSA-N
7051	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Yamakura T (2000)	10735801	176162	446	Pethidine	Meperidine|Petidina|Pethidinum|Sauteralgyl|Spasmodolin|Petydyna|Spasmedal|Pthidine|Isonipecane|Pethidin|Pethidine dbl	demerol 50 mg/ml   (multiple d	DRUGBANK	DB00454	C15H21NO2	small molecule	N02AB02|N02AB52|N02AG03|N02AB72	57-42-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XADCESSVHJOZHK-UHFFFAOYSA-N
7169	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7170	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7174	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7175	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7176	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7177	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7178	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7179	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7180	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	455	Metharbital	Metharbital|Metharbitalum|Metarbital	-	DRUGBANK	DB00463	C9H14N2O3	small molecule	N03AA30	50-11-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FWJKNZONDWOGMI-UHFFFAOYSA-N
7211	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7212	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7213	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7214	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Richter D (2010)	20491873	176266	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7215	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Law RJ (2008)	18446586	176267	458	Picrotoxin	cocculin	-	DRUGBANK	DB00466	C30H34O13	small molecule	-	124-87-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VJKUPQSHOVKBCO-ZTYBEOBUSA-N
7264	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7265	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7266	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7267	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Koltchine VV (1996)	9014160	176312	466	Methohexital	(+-)-5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)barbituric acid|alpha-DL-1-Methyl-5-allyl-5-(1'-methylpentyn-2-yl)barbituric acid|5-Allyl-5-(3-hexyn-2-yl)-1-methylbarbituric acid|Methohexital|5-Allyl-1-methyl-5-(1-methyl-2-pentynyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|Methohexitone|5-Allyl-1-methyl-5-(1-methyl-pent-2-ynyl)-pyrimidine-2,4,6-trione|Methohexitalum|Metohexital	brietal sodium ampoule 660|bre	DRUGBANK	DB00474	C14H18N2O3	small molecule	N01AF01|N05CA15	151-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZXKDOXHBHYTKP-UHFFFAOYSA-N
7278	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Skerritt JH (1983)	6135616	176313	467	Chlordiazepoxide	Chloradiazepoxide|Methaminodiazepoxide|Risolid|Silibrin|Clopoxide|Tropium|Libritabs|CDP|7-chloro-2-Methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide|Helogaphen|Multum|Chlordiazepoxide base|Chlordiazepoxidum	chlordiazepoxide hydrochloride	DRUGBANK	DB00475	C16H14ClN3O	small molecule	N05BA02	58-25-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ANTSCNMPPGJYLG-UHFFFAOYSA-N
7560	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7561	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gallagher MJ (1998)	9572299	176543	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7562	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Hattori K (2006)	16407246	176542	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7563	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Zhuravliova E (2007)	17092607	176545	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7564	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Gu WH (2007)	17588330	176544	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7565	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Sinor JD (2000)	11102491	176547	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7566	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Steinmetz RD (2002)	11741727	176546	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7806	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7807	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7808	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	526	Guanidine	Gu|Iminourea|Aminomethanamidine|Imidourea|Guanidin|H2N-C(=NH)-NH2|GUANIDINE	guanidine hydrochloride	DRUGBANK	DB00536	CH5N3	small molecule	-	113-00-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRALSGWEFCBTJO-UHFFFAOYSA-N
7864	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Buckley NA (1998)	9589848	176777	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7908	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	binder	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7944	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Lahti RA (1983)	6320036	176808	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
7945	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sethy VH (1984)	6148400	176809	536	Adinazolam	Adinazolamum|8-Chloro-1-((dimethylamino)methyl)-6-phenyl-4H-S-triazolo(4,3-a)(1,4)benzodiazepine	-	DRUGBANK	DB00546	C19H18ClN5	small molecule	N05BA07	37115-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJSLOMWRLALDCT-UHFFFAOYSA-N
8018	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8019	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8020	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Lipkind GM (2005)	16174788	176847	545	Lamotrigine	Lamotrigina|Lamotriginum|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|Lamotrigine|Lamictal	ratio-lamotrigine|dom-lamotrig	DRUGBANK	DB00555	C9H7Cl2N5	small molecule	N03AX09	84057-84-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PYZRQGJRPPTADH-UHFFFAOYSA-N
8311	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Xiong Q (2008)	18206251	177098	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8312	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8478	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8479	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8483	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Grasshoff C (2008)	18619475	177194	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8484	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8485	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8486	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8487	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	589	Thiopental	Thiopentobarbital|(+-)-Thiopental|Tiopentale|Sodium Pentothal|Thiopental|2-Thio-5-ethyl-5-sec-pentylbarbituric acid|Omexolon|Thiomebumalum|Penthiobarbital|5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione|Pentothiobarbital|Thiopentobarbitone|Bitaryl|Thiopentobarbituric acid|Thiopentone|Trapanal	pentothal inj 25mg/ml|pentotha	DRUGBANK	DB00599	C11H18N2O2S	small molecule	N05CA19|N01AF03	76-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUJDSEJGGMCXSG-UHFFFAOYSA-N
8786	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
8787	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	618	Clorazepate	Clorazepic acid|7-chloro-2,3-dihydro-2,2-Dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid|Clorazepate	novo-clopate cap 3.75mg|cloraz	DRUGBANK	DB00628	C16H11ClN2O3	small molecule	-	23887-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XDDJGVMJFWAHJX-UHFFFAOYSA-N
9083	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive modulator	target	Williams SH (2005)	16300039	177608	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9095	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Witkiewitz K (2012)	22346357	177609	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9096	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Mann K (2008)	18540918	177610	649	Acamprosate	N-acetyl homotaurine|N-Acetylhomotaurine|Acamprosato|Acamprosatum|3-Acetamido-1-propanesulfonic acid	campral|acamprosate calcium	DRUGBANK	DB00659	C5H11NO4S	small molecule	N07BB03	77337-76-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFCGFAGUEYAMAO-UHFFFAOYSA-N
9448	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9449	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	673	Midazolam	Buccolam|Midazolam|Dormicum|Midazolamum	midazolam injection sdz|midazo	DRUGBANK	DB00683	C18H13ClFN3	small molecule	N05CD08	59467-70-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDLIGBOFAVUZHB-UHFFFAOYSA-N
9520	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
9521	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	680	Flurazepam	Insumin|Flurazpam|Flurazepam|Flurazepamum	dalmane|somnol 30mg|flurazepam	DRUGBANK	DB00690	C21H23ClFN3O	small molecule	N05CD01	17617-23-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SAADBVWGJQAEFS-UHFFFAOYSA-N
10110	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	McCracken ML (2010)	20826568	178200	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10111	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10112	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10113	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Seo K (2010)	20097266	178199	743	Isoflurane	1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether|Forene|Aerrane|Forane|Ethane|Isofluranum|Isoflurano|Isoflurane	isoflurane usp|terrell|isoflur	DRUGBANK	DB00753	C3H2ClF5O	small molecule	N01AB06	26675-46-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIWKPBJCKXDKJR-UHFFFAOYSA-N
10520	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10521	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10525	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10526	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10527	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10528	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10529	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10530	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10531	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	784	Primidone	Primidona|Primidonum|Mysoline|Primidone|Desoxyphenobarbital|Primaclone|Primidon|5-Phenyl-5-ethyl-hexahydropyrimidine-4,6-dione	mysoline|primidone|sertan tab 	DRUGBANK	DB00794	C12H14N2O2	small molecule	N03AA03	125-33-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DQMZLTXERSFNPB-UHFFFAOYSA-N
10643	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10644	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Wamsley JK (1985)	2867566	178449	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10645	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Iorio LC (1984)	6738302	178448	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10646	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10647	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	791	Halazepam	Paxipam|Halazpam|Halazepamum|Halazepam	-	DRUGBANK	DB00801	C17H12ClF3N2O	small molecule	N05BA13	23092-17-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WYCLKVQLVUQKNZ-UHFFFAOYSA-N
10798	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Haeseler G (2008)	18574460	178526	808	Propofol	Propofol|Diprivan|Disoprofol|2,6-Bis(1-methylethyl)phenol|Propofolum|2,6-Diisopropylphenol|Rapinovet|Disoprivan	pms-propofol|propofol-ii injec	DRUGBANK	DB00818	C12H18O	small molecule	N01AX10	2078-54-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLBCVFGFOZPWHH-UHFFFAOYSA-N
10882	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10883	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10884	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	819	Diazepam	Diazepam|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Methyl diazepinone|Valium	pms-diazepam solution 1mg/ml|d	DRUGBANK	DB00829	C16H13ClN2O	small molecule	N05BA01	439-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AAOVKJBEBIDNHE-UHFFFAOYSA-N
10988	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Grech DM (1993)	7831422	178631	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10989	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Fadda F (1985)	2985405	178630	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10990	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Agmo A (1998)	9443561	178632	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10991	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
10992	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	827	Progabide	Progabida|Progabidum|Progabide|Halogabide	-	DRUGBANK	DB00837	C17H16ClFN2O2	small molecule	N03AG05	62666-20-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IBALRBWGSVJPAP-FXBPSFAMSA-N
11015	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11016	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	832	Oxazepam	Oxazepam|Tazepam|Serax|(+-)-Oxazepam|(RS)-Oxazepam	oxazepam 15mg tablets|apo oxaz	DRUGBANK	DB00842	C15H11ClN2O2	small molecule	N05BA04	604-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADIMAYPTOBDMTL-UHFFFAOYSA-N
11112	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11113	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11117	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11118	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11119	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11120	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Olsen RW (2011)	21194017	178688	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11121	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Roden WH (2010)	20692323	178689	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11122	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11123	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11124	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11125	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	839	Methylphenobarbital	Mephobarbital|Mebaral|5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylphenobarbitone|Methylphenobarbital|Enphenemal|Mthylphnobarbital|Metilfenobarbitale|5-Ethyl-1-methyl-5-phenylbarbituric acid|Metilfenobarbital|N-Methylphenobarbital|Mephobarbitone|5-Ethyl-1-methyl-5-phenyl-pyrimidine-2,4,6-trione|1-Methylphenobarbital|Methylphenobarbitalum	-	DRUGBANK	DB00849	C13H14N2O3	small molecule	N03AA01	115-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALARQZQTBTVLJV-UHFFFAOYSA-N
11472	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11473	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	887	Triazolam	Triazolam|Halcion|Triazolamum	penta-triazolam tablets|halcio	DRUGBANK	DB00897	C17H12Cl2N4	small molecule	N05CD05	28911-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOFWLTCLBGQGBO-UHFFFAOYSA-N
11505	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11506	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11507	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11508	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Earl DE (2011)	21262851	178936	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11509	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Santhakumar V (2007)	17591544	178935	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
11601	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11602	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11603	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Henjum S (2007)	17069932	178990	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11604	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Pollack MH (2005)	16420077	178991	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11605	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sheehan DV (2007)	18007567	178992	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11606	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Foster AC (2006)	16377242	178993	896	Tiagabine	Tiagabinum|Gabitril|Tiagabina	gabitril|tiagabine hydrochlori	DRUGBANK	DB00906	C20H25NO2S2	small molecule	N03AG06	115103-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBJUNZJWGZTSKL-MRXNPFEDSA-N
11824	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Leppik IE (2004)	15511691	179038	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11825	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Kothare SV (2008)	18433351	179039	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11826	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Sobieszek G (2004)	14704463	179034	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11827	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Schulze-Bonhage A (2010)	20001433	179035	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11828	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Zaccara G (2009)	19557119	179036	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11829	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Janszky J (2009)	20025128	179037	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
11830	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	inhibitor	target	Sonsalla PK (2010)	19948168	179031	899	Zonisamide	1,2-Benzisoxazole-3-methanesulfonamide|Zonisamida|Zonisamidum|Benzo[D]isoxazol-3-yl-methanesulfonamide|3-(Sulfamoylmethyl)-1,2-benzisoxazole	zonegran|zonisamide	DRUGBANK	DB00909	C8H8N2O3S	small molecule	N03AX15	68291-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UBQNRHZMVUUOMG-UHFFFAOYSA-N
12128	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Peretz A (2005)	15598972	177097	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12201	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Harty TP (2000)	10690753	179282	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12202	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Luszczki JJ (2008)	18253065	179281	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12203	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chang HR (2008)	18311896	179280	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12204	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12205	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kleckner NW (1999)	10215667	179279	939	Felbamate	Felbamatum|2-Phenyl-1,3-propanediol dicarbamate|Carbamic acid 2-phenyltrimethylene ester|Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester|Felbamato|Felbamate	felbamate|felbatol	DRUGBANK	DB00949	C11H14N2O4	small molecule	N03AX10	25451-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WKGXYQFOCVYPAC-UHFFFAOYSA-N
12322	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Patat A (2001)	12404558	179361	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12323	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sanger DJ (1999)	10515302	179362	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12324	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Barbera J (2005)	15783240	179363	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12325	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Terzano MG (2003)	12608888	179364	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12326	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12327	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	952	Zaleplon	3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide	starnoc|zaleplon|sonata	DRUGBANK	DB00962	C17H15N5O	small molecule	N05CF03	151319-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNXMJYCHXQEGX-UHFFFAOYSA-N
12604	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	unknown	target	Shimoyama M (2000)	10781913	179586	986	Gabapentin	Gabapentine|Gabapentin GR|Gabapentina|Gabapetin|Neurontin|Gabapentino|1-(Aminomethyl)cyclohexaneacetic acid|Gabapentinum	gapeam budibac|neurontin 600mg	DRUGBANK	DB00996	C9H17NO2	small molecule	N03AX12	60142-96-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UGJMXCAKCUNAIE-UHFFFAOYSA-N
12928	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12929	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12930	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12931	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Moody EJ (1988)	2459308	179764	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12932	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Krasowski MD (2000)	10683198	179765	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
12933	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Moody EJ (1988)	2845216	179766	1017	Methoxyflurane	Penthrane|Methoflurane|Methoxyfluranum|Methoxyfluran|Methyl 1,1-difluoro-2,2-dichloroethyl ether|Methoxyfluoran|Metoxiflurano	-	DRUGBANK	DB01028	C3H4Cl2F2O	small molecule	N02BG09	76-38-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFKMCNOHBTXSMU-UHFFFAOYSA-N
13118	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Blanpied TA (1997)	9120573	179867	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13119	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Maler JM (2005)	16009352	179865	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13120	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Nakazato E (2005)	15452358	179873	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13121	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Kashiwagi K (2002)	11854433	179872	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13122	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Rogawski MA (2003)	14530799	179868	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13188	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Korneyev AY (1996)	8786706	179892	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13189	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Tvrdeic A (2003)	12955907	179898	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13190	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Tvrdeic A (1991)	1664802	179897	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13392	112023	6096	-	RORB	NR1F2|ROR-BETA|RZR-BETA|RZRB|bA133M9.1	9606	Homo sapiens	agonist	target	Becker-Andre M (1994)	7961794	179959	1053	Melatonin	5-methoxy-N-acetyltryptamine|Melatonin|N-Acetyl-5-methoxytryptamine|Melatonine|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide	-	DRUGBANK	DB01065	C13H16N2O2	small molecule	N05CH01	73-31-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DRLFMBDRBRZALE-UHFFFAOYSA-N
13429	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13430	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1056	Clonazepam	5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one|1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one|CLONAZEPAM|5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one|5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Clonazepamum	pms-clonazepam tab 1.0mg|klono	DRUGBANK	DB01068	C15H10ClN3O3	small molecule	N03AE01	1622-61-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DGBIGWXXNGSACT-UHFFFAOYSA-N
13814	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13815	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13816	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
13817	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	de Fiebre CM (1992)	1352660	180182	1095	Methyprylon	Noludar|Methyprylon|Methyprolon|Metiprilona|Metiprilon|Metiprilone|Methyprylone|Methyprylonum|Methprylon	-	DRUGBANK	DB01107	C10H17NO2	small molecule	N05CE02	125-64-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SIDLZWOQUZRBRU-UHFFFAOYSA-N
14281	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14282	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14283	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Krasowski MD (1999)	10487207	174567	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14284	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Grasshoff C (2008)	18619475	177194	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14285	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Sugimura M (2002)	11900777	180392	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14286	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Mehta AK (1999)	10209232	174569	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14287	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Yamakura T (2001)	11264449	174568	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14288	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Whiting PJ (2003)	14579514	174584	1142	Thiamylal	5-Allyl-5-(1-methylbutyl)-2-thiobarbituric acid|Thioseconal|5-Allyl-5-(1-methylbutyl)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione|dihydro-5-(1-Methylbutyl)-5-(2-propenyl)-2-thioxo-4,6(1H,5H)-pyrimidinedione|5-Allyl-5-(1-methylbutyl)-2-thioxodihydro-4,6(1H,5H)-pyrimidinedione|Thiamylal	-	DRUGBANK	DB01154	C12H18N2O2S	small molecule	-	77-27-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XLOMZPUITCYLMJ-UHFFFAOYSA-N
14347	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14348	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1147	Halothane	Rhodialothan|1-Bromo-1-chloro-2,2,2-trifluoroethane|Bromochlorotrifluoroethane|Halothane|Narcotane|Halothanum|Fluothane|1,1,1-Trifluoro-2-chloro-2-bromoethane|Phthorothanum|Halotano|2,2,2-Trifluoro-1-chloro-1-bromoethane|1,1,1-Trifluoro-2-bromo-2-chloroethane|Ftorotan|2-Bromo-2-Chloro-1,1,1-Trifluoroethane	fluothane liq inh 1000mg/gm|ha	DRUGBANK	DB01159	C2HBrClF3	small molecule	N01AB01	151-67-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCQZXOMGPXTTIC-UHFFFAOYSA-N
14453	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14454	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14455	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Jin LJ (2010)	20051697	180468	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14459	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14460	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14461	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14462	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Macdonald RL (1986)	2871724	180469	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14463	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14464	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14465	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14474	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Daniell LC (1994)	7862741	175103	1162	Phenobarbital	Phenobarbitol|5-Phenyl-5-ethylbarbituric acid|PHENYLETHYLMALONYLUREA|5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione|Phenobarbitone|Luminal|5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Phenobarbital|Phenylaethylbarbitursaeure|5-Ethyl-5-phenylbarbituric acid|Phenylethylbarbituric Acid|Phenylethylbarbiturate|Phenobarbituric Acid|5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione|Phenylethylbarbitursaeure	phenobarbital sodium injection	DRUGBANK	DB01174	C12H12N2O3	small molecule	N03AA02	50-06-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DDBREPKUVSBGFI-UHFFFAOYSA-N
14650	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Moehler H (2002)	11752090	174537	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14651	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	positive allosteric modulator	target	Riss J (2008)	18384456	174202	1177	Desflurane	(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether|Desflurano|Desflurane|Suprane|1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane|Desfluranum|Difluoromethyl 1,2,2,2-tetrafluoroethyl ether	desflurane|suprane	DRUGBANK	DB01189	C3H2F6O	small molecule	N01AB07	57041-67-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DPYMFVXJLLWWEU-UHFFFAOYSA-N
14708	110303	4130	-	MAP1A	MAP1L|MTAP1A	9606	Homo sapiens	antagonist	target	Stearns ME (1991)	1647395	180566	1184	Estramustine	Estramustinum|Estradiol 3-(N,N-bis(2-chloroethyl)carbamate)|17beta-Estradiol 3-(bis(2-chloroethyl)carbamate)|17-Estradiol 3-(bis(2-chloroethyl)carbamate)|Estramustina|Estramustine	emcyt cap 140mg|emcyt	DRUGBANK	DB01196	C23H31Cl2NO3	small molecule	L01XX11	2998-57-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FRPJXPJMRWBBIH-RBRWEJTLSA-N
14750	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Hanson SM (2008)	18973287	175858	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14751	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Skerritt JH (1983)	6135616	176313	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14752	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Ramerstorfer J (2010)	20303942	180585	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14753	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Sanger DJ (2004)	15291009	180586	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14754	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nutt DJ (2010)	19942638	175857	1186	Zopiclone	6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate|(+-)-zopiclone|Zopiclonum|()-zopiclone|Zopiclona|Zopiclone	pro-zopiclone|nu-zopiclone tab	DRUGBANK	DB01198	C17H17ClN6O3	small molecule	N05CF01	43200-80-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBBSUAFBMRNDJC-UHFFFAOYSA-N
14845	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14846	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Whitwam JG (1995)	8693922	180623	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14847	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Wingrove PB (2002)	11864636	180625	1193	Flumazenil	Flumazepil|Flumazenilum|Anexate|Lanexat|Flumazenilo	flumazenil injection|flumazeni	DRUGBANK	DB01205	C15H14FN3O3	small molecule	V03AB25	78755-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFBIFZUFASYYRE-UHFFFAOYSA-N
14922	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Miller LG (1987)	2889803	180661	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
14923	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Braestrup C (1978)	639854	180662	1203	Estazolam	Estazolamum|8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine	prosom tab 2mg|prosom tab 1mg|	DRUGBANK	DB01215	C16H11ClN4	small molecule	N05CD04	29975-16-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CDCHDCWJMGXXRH-UHFFFAOYSA-N
15202	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15203	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	1224	Sevoflurane	Sevoflurano|Sevoflurane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevofluran|Sevofluranum	ultane|sevorane af|sevoflurane	DRUGBANK	DB01236	C4H3F7O	small molecule	N01AB08	28523-86-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DFEYYRMXOJXZRJ-UHFFFAOYSA-N
15920	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1307	Dihydroquinidine barbiturate	-	-	DRUGBANK	DB01341	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15921	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1307	Dihydroquinidine barbiturate	-	-	DRUGBANK	DB01341	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
15931	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15932	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Stobbs SH (2004)	15169831	181134	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15933	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15939	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Stobbs SH (2004)	15169831	181134	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15940	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15941	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15942	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15943	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15944	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1311	Quinidine barbiturate	-	-	DRUGBANK	DB01346	C32H36N4O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YHRUERMOPBDCFD-UHFFFAOYSA-N
15966	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15967	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15971	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15972	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15973	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15974	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15975	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1315	Amobarbital	5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione|5-Ethyl-5-isopentylbarbituric acid|Amylobarbitone|Barbamyl|5-Ethyl-5-isoamylbarbituric acid|Amobarbital|Amytal|5-Ethyl-5-(3-methylbutyl)barbituric acid|Barbamil	amytal sodium pulvule 222 0.2g	DRUGBANK	DB01351	C11H18N2O3	small molecule	N05CA02	57-43-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VIROVYVQCGLCII-UHFFFAOYSA-N
15990	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15991	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15995	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15996	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15997	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
15998	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1316	Aprobarbital	5-Allyl-5-isopropylbarbituric acid|Alurate|5-Allyl-5-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione|5-Isopropyl-5-allylbarbituric acid|Aprobarbital|Allypropymal|5-(1-Methylethyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione	-	DRUGBANK	DB01352	C10H14N2O3	small molecule	N05CA05	77-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UORJNBVJVRLXMQ-UHFFFAOYSA-N
16013	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16014	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16018	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16019	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16020	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16021	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16022	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16023	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16024	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1317	Butethal	Butobarbitone|Butobarbital|Butethal|Neonal	-	DRUGBANK	DB01353	C10H16N2O3	small molecule	N05CA03	77-28-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STDBAQMTJLUMFW-UHFFFAOYSA-N
16039	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16040	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16044	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16045	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16046	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16047	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1318	Heptabarbital	Heptabarbital|Heptabarbum|Medapan|Heptamal|Heptabarbitone|Medomine|Heptbarbital|Heptabarb|Heptamalum|Heptadorm	-	DRUGBANK	DB01354	C13H18N2O3	small molecule	N05CA11	509-86-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAZQYDJGLKSCSI-UHFFFAOYSA-N
16062	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16063	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16067	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16068	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16069	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16070	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Tomlin SL (1999)	10360871	181142	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16071	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16072	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16073	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16074	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1319	Hexobarbital	5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione|Evipan|Hexobarbital|5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid|Hexobarbitone|5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione|Methylhexabital|Methexenyl	-	DRUGBANK	DB01355	C12H16N2O3	small molecule	N05CA16|N01AF02	56-29-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYXAWHWODHRRMR-UHFFFAOYSA-N
16270	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	negative modulator	target	Hanrahan JR (2003)	12824018	181231	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16678	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Skerritt JH (1983)	6318143	181416	1385	Glutethimide	Doriden|2-Ethyl-2-phenylglutarimide	-	DRUGBANK	DB01437	C13H15NO2	small molecule	N05CE01	77-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JMBQKKAJIKAWKF-UHFFFAOYSA-N
16785	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16786	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16790	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16791	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16792	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16793	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1429	Barbital	-	-	DRUGBANK	DB01483	C8H12N2O3	small molecule	N05CA04	57-44-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTOAOBMCPZCFFF-UHFFFAOYSA-N
16815	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16816	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	antagonist	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16820	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Krasowski MD (1999)	10487207	174567	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16821	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mehta AK (1999)	10209232	174569	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16822	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Yamakura T (2001)	11264449	174568	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16823	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Whiting PJ (2003)	14579514	174584	1441	Barbituric acid derivative	-	-	DRUGBANK	DB01496	C16H11F3N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNZPLHRZXUJATK-UHFFFAOYSA-N
16873	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Stirling JM (1989)	2538766	181476	1460	Tenocyclidine	TCP	-	DRUGBANK	DB01520	C15H23NS	small molecule	-	21500-98-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JUZZEWSCNBCFRL-UHFFFAOYSA-N
16937	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1498	Bromazepam	Bromazepamum|Lectopam	alti-bromazepam 1.5mg tablets|	DRUGBANK	DB01558	C14H10BrN3O	small molecule	N05BA08	1812-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMIYHDSEFNYJSL-UHFFFAOYSA-N
16957	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Baburin I (2008)	18604239	181509	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
16958	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Mandrioli R (2008)	18855614	181508	1499	Clotiazepam	Clotiazepamum|Rize	-	DRUGBANK	DB01559	C16H15ClN2OS	small molecule	N05BA21	33671-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHBRHODLKOZEPZ-UHFFFAOYSA-N
17002	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Nakatsuka I (1985)	2857046	181520	1507	Fludiazepam	Erispan|Fludiazepamum|7-chloro-5-(O-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01567	C16H12ClFN2O	small molecule	N05BA17	3900-31-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ROYOYTLGDLIGBX-UHFFFAOYSA-N
17138	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Derry JM (2004)	15009644	178582	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17139	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17140	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17141	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Blaschke G (1986)	2874815	181548	1526	Ketazolam	U-28774|Ketazolam	loftran cap 30mg	DRUGBANK	DB01587	C20H17ClN2O3	small molecule	N05BA10	27223-35-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWAJCNITSBZRBL-UHFFFAOYSA-N
17154	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17155	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Amin J (1997)	9145922	181551	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17156	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17157	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1527	Prazepam	Centrax|Prazepamum	-	DRUGBANK	DB01588	C19H17ClN2O	small molecule	N05BA11	2955-38-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWQCHHACWWAQLJ-UHFFFAOYSA-N
17174	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Imming P (2006)	17016423	171742	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17175	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17176	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Overington JP (2006)	17139284	171741	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17177	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Billard W (1988)	2892106	181552	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17178	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Meldrum BS (1986)	3017690	181553	1528	Quazepam	Doral|Quazepamum	doral|quazepam	DRUGBANK	DB01589	C17H11ClF4N2S	small molecule	N05CD10	36735-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKMPWMZBZSAONZ-UHFFFAOYSA-N
17227	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Amin J (1997)	9145922	181551	1533	Cinolazepam	7-chloro-5-(O-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile|Cinolazepamum|7-chloro-5-(2-Fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile|1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one	-	DRUGBANK	DB01594	C18H13ClFN3O2	small molecule	N05CD13	75696-02-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XAXMYHMKTCNRRZ-UHFFFAOYSA-N
17246	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Chen X (2002)	11752352	171740	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17247	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Riss J (2008)	18384456	174202	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17248	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Moehler H (2002)	11752090	174537	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17249	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Tanaka M (2008)	18603831	181563	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17250	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	potentiator	target	Podhorna J (2000)	10877119	181562	1534	Nitrazepam	Paxisyn|7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Somitran|Nelbon|Sonebon|Gerson|Calsmin|Benzalin|Unisomnia|Relact|Radedorm|Trazenin|Neozepam|Hipnax|Persopit|Ibrovek|Surem|2,3-dihydro-7-Nitro-5-phenyl-1H-1,4-benzodiazepin-2-one|Eatan|Eunoctin|Ro 5-3059|Nitrazepamum|Neuchlonic|Ro 4-5360|Mogadon|Imesont|Sonnolin|N-Desmethylnimetazepam|Pelson|Apodorm|1,3-dihydro-7-Nitro-5-phenyl-2H-1,4-benzodiazepin-2-one|Hipsal|Nelmat|Atempol|Nitrados|7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|Remnos|Imeson	sandoz nitrazepam|nitrazepam-1	DRUGBANK	DB01595	C15H11N3O3	small molecule	N05CD02	146-22-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KJONHKAYOJNZEC-UHFFFAOYSA-N
17502	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17503	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1586	7-Methyl-Gpppa	P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE	-	DRUGBANK	DB01649	C21H30N10O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQOHNVHGNZYSBP-XPWFQUROSA-O
17528	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17529	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17530	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1600	(S)-Des-Me-Ampa	(S)-2-AMINO-3-(3-HYDROXY-ISOXAZOL-4-YL)PROPIONIC ACID	-	DRUGBANK	DB01664	C6H8N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKLGQYGPVBFAQQ-BYPYZUCNSA-N
17602	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	agonist	target	Compagnone NA (1998)	9539798	181620	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17624	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Sousa A (1997)	9262347	181622	1643	Prasterone	Dehydroandrosterone|3-hydroxyandrost-5-en-17-one|Dehydroepiandrosterone|Dehydroisoandrosterone|5-dehydroepiandrosterone|3beta-hydroxyandrost-5-en-17-one|3-beta-Hydroxy-5-androsten-17-one|5-DHEA|DHEA	prastera	DRUGBANK	DB01708	C19H28O2	small molecule	A14AA07|G03EA03	53-43-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FMGSKLZLMKYGDP-USOAJAOKSA-N
17741	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1698	(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid	-	-	DRUGBANK	DB01765	C17H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	INSBKYCYLCEBOD-UHFFFAOYSA-N
18134	108100	1760	-	DMPK	DM|DM1|DM1PK|DMK|MDPK|MT-PK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1870	3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione	-	-	DRUGBANK	DB01946	C24H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UQHKJRCFSLMWIA-UHFFFAOYSA-N
18175	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18176	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18177	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1884	7n-Methyl-8-Hydroguanosine-5'-Diphosphate	-	-	DRUGBANK	DB01960	C11H19N5O11P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQODJOAVWUWVHJ-FCIPNVEPSA-N
18224	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18225	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18226	108086	1742	-	DLG4	PSD95|SAP-90|SAP90	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1896	Guanosine-5'-Monophosphate	-	-	DRUGBANK	DB01972	C10H14N5O8P	small molecule	-	85-32-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQFCJASXJCIDSX-BZKDHIKHSA-N
18419	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18420	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18421	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1978	(S)-AMPA	(S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid	-	DRUGBANK	DB02057	C7H10N2O4	small molecule	-	83643-88-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UUDAMDVQRQNNHZ-YFKPBYRVSA-N
18660	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2086	1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One	-	-	DRUGBANK	DB02170	C13H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZOHCDJRFYXKEQW-UHFFFAOYSA-N
19002	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19003	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19004	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2252	2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB02347	C11H19N2O7P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGSOOCUNMTYPSE-ZETCQYMHSA-N
19744	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19758	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19759	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19760	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2604	7-Methyl-Guanosine-5'-Triphosphate	-	-	DRUGBANK	DB02716	C11H19N5O14P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKVRNHPCAOHRSI-FCIPNVEPSA-O
19954	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
19955	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
19956	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2700	Iodo-Willardiine	-	-	DRUGBANK	DB02818	C7H8IN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AXXYLTBQIQBTES-BYPYZUCNSA-N
20208	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20209	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20210	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2843	Fluoro-Willardiine	-	-	DRUGBANK	DB02966	C7H8FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DBWPFHJYSTVBCZ-BYPYZUCNSA-N
20262	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20263	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20264	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2875	Quisqualate	-	-	DRUGBANK	DB02999	C5H7N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ASNFTDCKZKHJSW-REOHCLBHSA-N
20361	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2908	1,8-Di-Hydroxy-4-Nitro-Anthraquinone	-	-	DRUGBANK	DB03035	C14H7NO6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RIYCICFDXLNQPV-UHFFFAOYSA-N
20540	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20541	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20542	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2996	Benzamidine	-	-	DRUGBANK	DB03127	C7H9N2	small molecule	-	618-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PXXJHWLDUBFPOL-UHFFFAOYSA-O
20807	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20808	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20809	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3108	(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid	-	-	DRUGBANK	DB03240	C10H13N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VSGUEKZRMJVQOH-LURJTMIESA-N
20966	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
20967	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
20968	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3184	(S)-ATPA	(S)-2-Amino-3-(3-Hydroxy-5-Tert-Butyl-Isoxazol-4-Yl)Propionic Acid	-	DRUGBANK	DB03319	C10H15N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PIXJURSCCVBKRF-ZCFIWIBFSA-M
21880	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
21881	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
21882	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3601	FG-9041	6,7-dinitroquinoxaline-2,3-dione|2,3-quinoxalinedione, 1,4-dihydro-6,7-dinitro-|6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione|DNQX	-	DRUGBANK	DB03759	C8H4N4O6	small molecule	-	2379-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWVIMCIPOAXUDG-UHFFFAOYSA-N
22156	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22157	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22158	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3741	Urea	-	uramaxin|umecta mousse urea|ca	DRUGBANK	DB03904	CH4N2O	small molecule	-	57-13-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSQUKJJJFZCRTK-UHFFFAOYSA-N
22197	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3760	5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone	-	-	DRUGBANK	DB03924	C14H10N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVEMRPAUHFWHRV-UHFFFAOYSA-N
22360	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22361	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22362	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3834	Bromo-Willardiine	-	-	DRUGBANK	DB04000	C7H8BrN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEKIJKSVXKWGRJ-BYPYZUCNSA-N
22611	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22612	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22613	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3961	Willardiine	-	-	DRUGBANK	DB04129	C7H9N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FACUYWPMDKTVFU-BYPYZUCNSA-N
22725	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
22726	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
22727	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3982	2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid	-	-	DRUGBANK	DB04152	C11H14N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HJEPOXZLPHUVFE-ZETCQYMHSA-N
23044	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23045	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23046	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4140	Guanosine-5'-Diphosphate	-	-	DRUGBANK	DB04315	C10H15N5O11P2	small molecule	-	146-91-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGWNDRXFNXRZMB-BZKDHIKHSA-N
23269	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23270	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23271	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4216	Phosphoaminophosphonic Acid-Adenylate Ester	-	-	DRUGBANK	DB04395	C10H17N6O12P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PVKSNHVPLWYQGJ-FCIPNVEPSA-N
23404	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23405	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23406	109032	2770	-	GNAI1	Gi	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4258	Tetrafluoroaluminate Ion	-	-	DRUGBANK	DB04444	AlF4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYOMQIYKOOHAMK-UHFFFAOYSA-J
23474	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23475	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23476	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4276	Tetrabromo-2-Benzotriazole	-	-	DRUGBANK	DB04462	C6HBr4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMZYUVOATZSGJY-UHFFFAOYSA-N
23759	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23841	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4523	DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE	-	-	DRUGBANK	DB04719	C9H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLPJGDQJLTYWCI-UHFFFAOYSA-N
23842	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4524	S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04720	C8H4Br4N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZIGJZZDDPXRGTL-UHFFFAOYSA-N
23843	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4525	N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE	-	-	DRUGBANK	DB04721	C10H7Br4N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QHCZROILDUNGRT-UHFFFAOYSA-N
23911	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4600	THIO-ATPA	-	-	DRUGBANK	DB04798	C10H16N2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHWOAQCPEFTDOQ-LURJTMIESA-N
24110	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Kohno T (2012)	22716121	182205	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24111	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	inhibitor	target	Shuto S (1995)	7636857	181687	4696	Milnacipran	Midalcipran|Milnacipranum|(-)-milnacipran|Milnacipran	milnacipran hydrochloride|save	DRUGBANK	DB04896	C15H22N2O	small molecule	N06AX17	92623-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJJFMKBJSRMPLA-HIFRSBDPSA-N
24219	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Punke MA (2007)	17456683	175184	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24220	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Hirano K (2007)	17184917	181979	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24221	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Main MJ (2000)	10908292	181758	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24222	109987	3786	-	KCNQ3	BFNC2|EBN2|KV7.3	9606	Homo sapiens	unknown	target	Wickenden AD (2000)	10953053	181759	4747	Ezogabine	Retigabine|RTG|N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester|Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate|N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester|Potiga|EZG|D-23129|Ethyl 2-amino-4-((P-fluorobenzyl)amino)carbanilate	potiga	DRUGBANK	DB04953	C16H18FN3O2	small molecule	N03AX21	150812-12-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCOBBVZJEWWZFR-UHFFFAOYSA-N
24268	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Denes L (2006)	16861112	181955	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24269	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Langan YM (2003)	12581229	181810	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24270	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Howes JF (2007)	17199027	181981	4774	Talampanel	-	-	DRUGBANK	DB04982	C19H19N3O3	small molecule	-	161832-65-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JACAAXNEHGBPOQ-LLVKDONJSA-N
24291	112231	6326	-	SCN2A	BFIC3|BFIS3|BFNIS|EIEE11|HBA|HBSCI|HBSCII|NAC2|Na(v)1.2|Nav1.2|SCN2A1|SCN2A2	9606	Homo sapiens	unknown	target	Sage D (2007)	17663442	182034	5011	Tetrodotoxin	-	-	DRUGBANK	DB05232	C11H17N3O8	small molecule	-	4368-28-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLBCPBUVHCASIJ-UFHSVNPDSA-O
24399	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	activator	target	Lipton SA (2002)	12183209	181801	5519	Acetylcysteine	(R)-Mercapturic acid|N-acetylcysteine|N-Acetyl-L-(+)-cysteine|(2R)-2-acetylamino-3-Sulfanylpropanoic acid|Acetilcisteina|Mercapturic acid|Acetylcysteine|Acetylcysteinum|L-Acetylcysteine|(R)-2-acetylamino-3-Mercaptopropanoic acid|N-ACETYL-L-cysteine|L-alpha-acetamido-beta-Mercaptopropionic acid	parvolex|parvolex liq iv 200mg	DRUGBANK	DB06151	C5H9NO3S	small molecule	V03AB23|S01XA08|R05CB01	616-91-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWKSKIMOESPYIA-BYPYZUCNSA-N
24606	109947	3745	-	KCNB1	DRK1|EIEE26|KV2.1|h-DRK1	9606	Homo sapiens	antagonist	target	Judge SI (2006)	16472864	181930	5565	Dalfampridine	Ampyra|4-Pyridylamine|Fampridinum|4-Pyridinamine|N07XX07|P-Aminopyridine|4-AP|EL-970|gamma-Aminopyridine|Dalfampridine|Avitrol|Fampridine-SR|Fampridine|4-Aminopyridine|Fampridina	fampyra|ampyra	DRUGBANK	DB06637	C5H6N2	small molecule	N07XX07	504-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NUKYPUAOHBNCPY-UHFFFAOYSA-N
24799	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Ebert B (1995)	7624018	181686	5615	Ketobemidone	Ketorax|Cetobemidona|Ketodur|Cliradon|Ketobemidone|Ketogan|Cetobemidone|Cymidon|Cetobemidonum	-	DRUGBANK	DB06738	C15H21NO2	small molecule	N02AB01|N02AG02	469-79-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ALFGKMXHOUSVAD-UHFFFAOYSA-N
24809	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Warach S (2005)	16340185	181922	5616	Gavestinel	-	-	DRUGBANK	DB06741	-	small molecule	-	153436-22-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
25471	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6266	N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide	-	-	DRUGBANK	DB07455	C20H28N2O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZESUARCHWPARIF-HOTGVXAUSA-N
25608	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6405	2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE	-	-	DRUGBANK	DB07598	C13H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQEPVMAYUINZRE-GFCCVEGCSA-N
25615	108192	1859	-	DYRK1A	DYRK|DYRK1|HP86|MNB|MNBH|MRD7	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6414	N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide	-	-	DRUGBANK	DB07608	C24H22ClN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDGOPNUGILVNJZ-IBGZPJMESA-N
25642	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6443	3,5 DIBROMOTYROSINE	-	-	DRUGBANK	DB07637	C9H9Br2NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	COESHZUDRKCEPA-ZETCQYMHSA-N
25721	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6518	Emodin	3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE|Emodin|Emodol|Frangula Emodin|Schuttgelb|1,3,8-Trihydroxy-6-Methylanthracene-9,10-Dione|Rheum Emodin|Archin	-	DRUGBANK	DB07715	C15H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHMXXJGYXNZAPX-UHFFFAOYSA-N
25828	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6600	3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE	-	-	DRUGBANK	DB07802	C10H6Br2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MSOLROYRAHCJNK-UHFFFAOYSA-N
26233	108292	1977	-	EIF4E	AUTS19|CBP|EIF4E1|EIF4EL1|EIF4F	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7008	2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL	-	-	DRUGBANK	DB08217	C9H17NOS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRRNXPDUICGIEB-UHFFFAOYSA-N
26342	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7090	(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide	-	-	DRUGBANK	DB08303	C18H28N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CUMKMTBOHBENJI-SFHVURJKSA-N
26343	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7091	(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	-	-	DRUGBANK	DB08304	C18H27N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZBQVXXESPXFPZ-QGZVFWFLSA-N
26344	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7092	(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide	-	-	DRUGBANK	DB08305	C19H29N3O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQAGZLQCEURCKJ-QGZVFWFLSA-N
26380	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7124	19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one	-	-	DRUGBANK	DB08338	C19H21N7O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIJNSOUPEZHEMC-UHFFFAOYSA-N
26382	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7126	N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB08340	C17H14N6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LLYYAUZAGCZEKV-UHFFFAOYSA-N
26390	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7130	4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08345	C17H15N9	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWUUKHQIKFHWIW-UHFFFAOYSA-N
26400	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7138	2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08353	C19H21N7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCVMTHVSAJMOPI-UHFFFAOYSA-N
26401	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7139	2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08354	C19H14ClN7	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QCVULERVJOYHCP-UHFFFAOYSA-N
26410	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7145	2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE	-	-	DRUGBANK	DB08360	C18H20N8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIFHJPUTQBOBGJ-UHFFFAOYSA-N
26412	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7147	N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE	-	-	DRUGBANK	DB08362	C20H16N8O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QVKXQLGRDOMAGC-UHFFFAOYSA-N
26522	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7254	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	-	-	DRUGBANK	DB08473	C12H12Cl2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XHSQDZXAVJRBMX-DDHJBXDOSA-N
26675	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7434	1,2,5,8-tetrahydroxyanthracene-9,10-dione	-	-	DRUGBANK	DB08660	C14H8O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VBHKTXLEJZIDJF-UHFFFAOYSA-N
26905	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26906	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Sekiguchi Y (2009)	19414254	182103	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26928	112420	6529	-	SLC6A1	GABATHG|GABATR|GAT1	9606	Homo sapiens	inhibitor	target	Sunol C (2010)	20512624	178994	7607	Guvacine	-	-	DRUGBANK	DB08848	C6H9NO2	small molecule	-	498-96-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTDZOWFRBNTPQR-UHFFFAOYSA-N
26963	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	stimulator	target	Woodburn KW (2013)	23318685	182225	7638	Peginesatide	Erythropoiesis-Stimulating Agent (ESA)|Hematide	-	DRUGBANK	DB08894	(C2H4O)n(C2H4O)nC229H344N62O58S6	small molecule	B03XA04	913976-27-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
26999	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Wizemann V (2008)	18208642	182063	7663	Epoetin Zeta	1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta	-	DRUGBANK	DB08923	C809H1301N229O240S5	biologic	-	604802-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27000	108371	2057	-	EPOR	EPO-R	9606	Homo sapiens	agonist	target	Barosi G (2011)	21719882	182192	7663	Epoetin Zeta	1-165-Erythropoietin (human clone B03XA01) glycoform zeta|Epoetinum zeta|Epoetina dseta|Epoetin zeta|Epotine zta	-	DRUGBANK	DB08923	C809H1301N229O240S5	biologic	-	604802-70-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
27011	109161	2904	-	GRIN2B	GluN2B|MRD6|NMDAR2B|NR2B|hNR3	9606	Homo sapiens	antagonist	target	Seppaelae T (1988)	3365283	181667	7690	Ifenprodil	-	-	DRUGBANK	DB08954	C21H27NO2	small molecule	C04AX28	23210-56-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UYNVMODNBIQBMV-UHFFFAOYNA-N
27180	109148	2891	-	GRIA2	GLUR2|GLURB|GluA2|GluR-K2|HBGR2	9606	Homo sapiens	unknown	target	Dopico AM (2009)	19270242	188491	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27704	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
27776	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	agonist	target	Davies M (2003)	12921221	195958	888	Ethanol	thanol|Methylcarbinol|Ethyl Alcohol|Alcohol|Alcohol etlico|thylalkohol|Grain alcohol|Alcohol (ethyl)|1-Hydroxyethane|Alcohol anhydrous|thanol|Alcohol, denatured|etanol|Dehydrated ethanol|Spiritus vini|Hydroxyethane|Alkohol|Alcool thylique|Alcohol denatured	lisa frank bubblegum antisepti	DRUGBANK	DB00898	C2H6O	small molecule	D08AX08|V03AB16|V03AZ01	64-17-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LFQSCWFLJHTTHZ-UHFFFAOYSA-N
27957	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Carta M (2006)	16806306	195970	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
27958	108828	2554	-	GABRA1	ECA4|EIEE19|EJM|EJM5	9606	Homo sapiens	antagonist	target	Mascia MP (2007)	17234181	195976	8251	Thiocolchicoside	Thiocolchicine 2-glucoside analog|TCC	-	DRUGBANK	DB11582	C27H33NO10S	small molecule	M03BX05|M03BX55	602-41-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEQAKWQJCITZNK-AXHKHJLKSA-N
28737	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Huang HT (2018)	29129717	211728	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide --- MARK2:TL13-87)	-
28919	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	degradation	target	Liao H (2020)	32550000	223654	8554	Bivalent ligand 154	xStAx-VHLL|Bivalent_ligand_154	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: xStAx-VHLL (VHL:VHL ligand --- CTNNB1:xStAx)	-
29276	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29277	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29278	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	9308	Midostaurin	CCG-101288|SB16639|HY-10230|HMS3229K17|CGP 41 251|ZINC100013130|MIDOSTAURIN(PKC412)|PKC 412|CGP 41251|N-[(2S,3R,4R,6R)-3-METHOXY-2-METHYL-16-OXO-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-4-YL]-N-METHYLBENZAMIDE|RYDAPT (TN)|PKC412|[9S-(9?,10?,11?,13?)]-N-(2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-1-OXO-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-11-YL)-N-METHYLBENZAMIDE|ACN-036840|4'-N-BENZOYLSTAUROSPORINE|BENZOYLSTAUROSPORINE|CGP-41251|MIDOSTAURIN [USAN:INN]|EX-A1741|N-BENZOYLSTAUROSPORINE|120685-11-2|D05029|CGP 41231|Q6842945|BRD-K13646352-001-01-2|DB06595|MIDOSTAURIN (JAN/USAN/INN)|CS-3331|NCGC00484987-03|Z-3116|N-[(5S,6R,7R,9R)-6-METHOXY-5-METHYL-14-OXO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-7-YL]-N-METHYLBENZAMIDE|CGP-41521|ID912S5VON|AKOS024457372|PKC-412|UNII-ID912S5VON|NCGC00241102-02|GTPL5702|NVP-PKC412|J-004379|RYDAPT|MIDOSTAURIN|S8064|NCGC00241102-01|BDBM50326053	-	PUBCHEM	9829523	C35H30N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BMGQWWVMWDBQGC-IIFHNQTCSA-N
29279	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Karaman MW (2008)	18183025	224791	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
29639	114491	9024	HUSSY-12	BRSK2	C11orf7|PEN11B|SAD1|SADA|STK29	9606	Homo sapiens	unknown	target	Bain J (2007)	17850214	224888	6832	Su6656	330161-87-0|NCGC00094279-01|B5839|HMS3648O08|NCGC00015981-09|N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|2,3-DIHYDRO-N,N-DIMETHYL-2-OXO-3-[(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE]-1H-INDOLE-5-SULFONAMIDE|EX-A584|4071AH|AKOS015994571|MLS002153475|HMS2232C04|INSOLUTION&TRADE; SU6656|LOPAC0_000979|EU-0100979|NCGC00261664-01|S7774|Q7394936|NCGC00015981-03|1240328-42-0|SU 6656|SR-01000076237-6|HMS3263C19|(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE|CCG-205059|SU-6656|SU6656|ES-0024|SU 6656, >=98% (HPLC)|SDCCGSBI-0050952.P003|NCGC00015981-04|NCGC00094279-02|LOPAC-S-9692|NCGC00015981-02|HSCI1_000124|SR-01000076237-1|HMS3229I04|SR-01000076237|CS-3943|GTPL6044|TOX21_500979|DB08039|(Z)-N,N-DIMETHYL-2-OXO-3-((4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)METHYLENE)INDOLINE-5-SULFONAMIDE|MFCD10565928|NCGC00015981-05|NCGC00015981-01|NCGC00015981-06|ZINC3875028|2-OXO-3-[1-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YL)-METH-(Z)-YLIDENE]-2,3-DIHYDRO-1H-INDOLE-5-SULFONIC ACID DIMETHYLAMIDE|SMR001230828|S 9692|LP00979|BRD-K97354755-001-01-5|HY-B0789|BDBM50307127	-	DRUGBANK	DB08039	C19H21N3O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LOGJQOUIVKBFGH-YBEGLDIGSA-N
29771	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	unknown	target	Fabian MA (2005)	15711537	224911	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
30630	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10010	Bivalent Ligand 264	SK-3-91|Bivalent_Ligand_264	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SK-3-91 (CRBN:pomalidomide--- MARK2:TAE684)	-
30792	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	8537	Bivalent ligand 120	TL12-186|Bivalent_ligand_120	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TL12-186 (CRBN:pomalidomide--- MARK2:TAE684)	-
31548	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10038	Bivalent Ligand 277	RSS0680|Bivalent_Ligand_277	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: RSS0680 (VHL:VHL-1--- MARK2:Thienopyrimidines)	-
31914	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10061	Bivalent Ligand 289	BSJ-04-178|Bivalent_Ligand_289	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-04-178 (CRBN:Thalidomide--- MARK2:MRT68921)	-
32108	108326	2011	-	MARK2	EMK-1|EMK1|PAR-1|Par-1b|Par1b	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10087	Bivalent Ligand 296	BSJ-05-026|Bivalent_Ligand_296	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BSJ-05-026 (VHL:VHL-1--- MARK2:MRT68921)	-
33284	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Yang X (2022)	35723434	232852	10245	SGC-CK2-1	Propanamide, N-[5-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-2-methylphenyl]-|N-(5-{[3-Cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}-2-methylphenyl)propanamide	-	CHEMSPIDER	98644473	C20H21N7O	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction:CSNK2A inhibitor; exact viral inhibition mechanism undetermined	YKDZIFFKQUNVHH-UHFFFAOYSA-N
33450	107841	1457	-	CSNK2A1	CK2A1|CKII|CSNK2A3	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Bouhaddou M (2020)	32645325	223689	10331	Silmitasertib	GTPL8126|J-516169|EX-8673|HMS3244N13|NSC-761193|AS-16253|EN300-6482034|5-[(3-CHLOROPHENYL)AMINO]PYRIDO[4,3-C]QUINOLINE-8-CARBOXYLIC ACID|SB17201|Q27076934|5-((3-CHLOROPHENYL)AMINO)BENZO-[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945|HMS3746E13|CX-4945 (SILMITASERTIB)|CCG-264955|BCP02399|HMS3244M14|SILMITASERTIB [INN]|HMS3244M13|1009820-21-6|CX-4945,CAS:1009820-21-6|5-(3-CHLOROPHENYLAMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)-BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|C19H12CLN3O2|5-[(3-CHLOROPHENYL)AMINO]-BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX-4945 FREE ACID|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|DB15408|SILMITASERTIBUM|5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|5-((3-CHLOROPHENYL)AMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|FT-0723994|5-[(3-CHLOROPHENYL)AMINO]BENZO[C]2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID|CS-0563|NCGC00263192-02|NCGC00263192-09|AC-28426|W-204393|HY-50855|SILMITASERTIB|J-000296|5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|BCP9000560|SILMITASERTIB; CX 4945|NSC-800885|CX-4945 (SILMITASERIB)|A25034|MFCD13184796|CX 4945 (SILMITASERTIB)|BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-|SY069677|DTXCID9066093|AKOS005266722|CX4945 (SILMITASERTIB)|C6RWP0N0L2|SW218157-2|SILMITASERTIB (CX-4945)|HMS3655F16|BENZO[C]-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-[(3-CHLOROPHENYL)AMINO]-|EX-A070|S2248|5-(3-CHLOROANILINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|CX4945|CX 4945|UNII-C6RWP0N0L2|DTXSID40143602|SILMITASERTIB [WHO-DD]|5-(3-CHLOROPHENYLAMINO)BENZO[C][2,6]NAPHTHYRIDINE-8-CARBOXYLIC ACID|NSC761193|3NG|NSC800885|NCGC00263192-01	-	PUBCHEM	24748573	C19H12ClN3O2	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: human CSNK2A1 and CSNK2A2 inhibitor;  antiviral activity against SARS-CoV-2 in Vero-E6 cells	MUOKSQABCJCOPU-UHFFFAOYSA-N
33465	107880	1499	OK/SW-cl.35	CTNNB1	CTNNB|MRD19|armadillo	9606	Homo sapiens	sars-cov-2 inhibitor	target	Kelch MA (2023)	37342561	241452	10338	Foscenvivint	2H-PYRAZINO(2,1-C)(1,2,4)TRIAZINE-1(6H)-CARBOXAMIDE, HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-((4-(PHOSPHONOOXY)PHENYL)METHYL)-8-(8-QUINOLINYLMETHYL)-, (6S,9S,9AS)-|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7- DIOXO-8-((QUINOLIN-8-YL)METHYL)OCTAHYDRO-2HPYRAZINO(2,1-C)(1,2,4)TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|1198780-38-9|43Y934BBZ6|UNII-43Y934BBZ6|PRI724|(S,S)-ICG-001|1422253-38-0 (PRI-724)|HY-112045|FOSCENVIVINT|EX-A3641|[4-[[(6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)-3,6,9,9A-TETRAHYDROPYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL]METHYL]PHENYL] DIHYDROGEN PHOSPHATE|DB15034|1422253-38-0|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-2H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|AC-31548||A-CATENIN/CBP-IN-1|4-(((6S,9S,9AS)-1-(BENZYLCARBAMOYL)-2,9-DIMETHYL-4,7-DIOXO-8-(QUINOLIN-8-YLMETHYL)OCTAHYDRO-1H-PYRAZINO[2,1-C][1,2,4]TRIAZIN-6-YL)METHYL)PHENYL DIHYDROGEN PHOSPHATE|PRI-724|FOSCENVIVINT [INN]|CS-0042484|(6S,9S,9AS)-HEXAHYDRO-2,9-DIMETHYL-4,7-DIOXO-N-(PHENYLMETHYL)-6-[[4-(PHOSPHONOOXY)PHENYL]METHYL]-8-(8-QUINOLINYLMETHYL)-2H-PYRAZINO[2,1-C][1,2,4]TRIAZINE-1(6H)-CARBOXAMIDE	-	PUBCHEM	71509318	C33H35N6O7P	small molecule	-	-	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: small-molecule inhibitor of the Beta-catenin/CBP interaction; shows anti-viral acitivity against multiple coronaviruses including SARS-CoV-2 variants (Ancestral variants: B (FFM5), B.1 (FFM7, D614G); variants of interest (VOI): P.2 (Zeta), B.1.429 (Epsilon), B.1.617.1 (Kappa); deescalated variants of concern (VOC): B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta); VOC: B.1.1.529 BA.1, BA.2, and BA.5 (Omicron), SARS-CoV-1, and Influenza A virus in A549-AT cells	VHOZWHQPEJGPCC-AZXNYEMZSA-N
